Reviewers: Komal Arora, M.D., (see Reviewers page)
Revised: 19 March 2012, last major update February 2012
Copyright: (c) 2003-2012, PathologyOutlines.com, Inc.
● Incidence is <0.6% of all prostate cancers
● Have normal serum PSA and PSAP levels
● Originates from the periurethral glands or prostatic acinar basal cells
● Either de novo or post-radiation or hormonal therapy for ordinary adenocarcinoma
● Both glandular (acinar) and squamous components
● Am J Surg Pathol 1987;11:403, Hum Pathol 1995;26:123, Hum Pathol 1984;15:87, BJU Int 2008;102:1369
End of Prostate > Other carcinomas > Adenosquamous carcinoma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at [email protected] with any questions (click here for other contact information).